From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors

RL Wahl, H Jacene, Y Kasamon… - Journal of nuclear …, 2009 - Soc Nuclear Med
The purpose of this article is to review the status and limitations of anatomic tumor response
metrics including the World Health Organization (WHO) criteria, the Response Evaluation …

Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development

GJ Kelloff, JM Hoffman, B Johnson, HI Scher… - Clinical Cancer …, 2005 - AACR
[18F] Fluoro-2-deoxyglucose positron emission tomography (FDG-PET) assesses a
fundamental property of neoplasia, the Warburg effect. This molecular imaging technique …

Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal …

F Tixier, CC Le Rest, M Hatt, N Albarghach… - Journal of Nuclear …, 2011 - Soc Nuclear Med
18F-FDG PET is often used in clinical routine for diagnosis, staging, and response to therapy
assessment or prediction. The standardized uptake value (SUV) in the primary or regional …

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

F Lordick, K Ott, BJ Krause, WA Weber, K Becker… - The lancet …, 2007 - thelancet.com
Background In patients with locally advanced adenocarcinoma of the oesophagogastric
junction (AEG), early metabolic response defined by 18-fluorodeoxyglucose-PET ([18 F] …

Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival

AC Berger, J Farma, WJ Scott, G Freedman… - Journal of Clinical …, 2005 - ascopubs.org
Purpose Attempts to improve survival of patients with esophageal cancer have been made
using induction chemoradiotherapy (CRT) followed by surgery. A large single-center …

Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment

HA Wieder, BLDM Brucher, F Zimmermann… - Journal of Clinical …, 2004 - ascopubs.org
Purpose To evaluate the time course of therapy-induced changes in tumor glucose use
during chemoradiotherapy of esophageal squamous cell carcinoma (ESCC) and to correlate …

Positron emission tomography in non–small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use

WA Weber, V Petersen, B Schmidt… - Journal of Clinical …, 2003 - ascopubs.org
Purpose: To prospectively evaluate the use of positron emission tomography with the
glucose analog fluorodeoxyglucose (FDG-PET) to predict response to chemotherapy in …

Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG

AK Buck, G Halter, H Schirrmeister… - Journal of nuclear …, 2003 - Soc Nuclear Med
Recently, the thymidine analog 3′-deoxy-3′-18F-fluorothymidine (FLT) was suggested for
imaging tumoral proliferation. In this prospective study, we examined whether 18F-FLT …

Esophageal and esophagogastric junction cancers

JA Ajani, JS Barthel, DJ Bentrem, TA D'Amico… - Journal of the National …, 2011 - jnccn.org
Esophageal and Esophagogastric Junction Cancers in: Journal of the National
Comprehensive Cancer Network Volume 9 Issue 8 (2011) Jump to Content User Account …

Use of PET for monitoring cancer therapy and for predicting outcome

WA Weber - Journal of Nuclear Medicine, 2005 - Soc Nuclear Med
PET with the glucose analog 18F-FDG is increasingly used to monitor tumor response in
patients undergoing chemotherapy and chemoradiotherapy. Numerous studies have shown …